TNF and metabolic disease: TNF-α inhibitors induce a marked improvement in the skin and joint symptoms of psoriasis [93], while in HCV-infected individuals, persistent inflammation mediated by TNF-α leads to liver cirrhosis and metabolic disorders [94].